Role of N6-methyladenosine modification in pathogenesis of ischemic stroke

References

• Manning NW, Campbell BC, Oxley TJ, et al. Acute ischemic stroke: time, penumbra, and reperfusion. Stroke. 2014;45(2):640–644.
   PubMed Web of Science ®Google Scholar
• Gropen TI, Gagliano PJ, Blake CA, et al. Quality improvement in acute stroke: the New York state stroke center designation project. Neurology. 2006;67(1):88–93.
   PubMed Web of Science ®Google Scholar
• Fisher M, Saver JL. Future directions of acute ischaemic stroke therapy. Lancet Neurol. 2015;14(7):758–767.
   PubMed Web of Science ®Google Scholar
• Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 2018;378(1):11–21.
   PubMed Web of Science ®Google Scholar
• Chokkalla AK, Mehta SL, Kim T, et al. Transient focal Ischemia significantly alters the m6A epitranscriptomic tagging of RNAs in the brain. Stroke. 2019;50(10):2912–2921.
   PubMed Web of Science ®Google Scholar
• Boccaletto P, Machnicka MA, Purta E, et al. MODOMICS: a database of RNA modification pathways. 2017 update. Nucleic Acids Res. 2018;46(D1):D303–D307.
   PubMed Web of Science ®Google Scholar
• Dominissini D, Moshitch-Moshkovitz S, Schwartz S, et al. Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature. 2012;485(7397):201–206.
   PubMed Web of Science ®Google Scholar
• Zhang C, Fu J, Zhou Y. A review in research progress concerning m6A methylation and immunoregulation. Front Immunol. 2019; 10:922. Published 2019 Apr 26.
   PubMed Web of Science ®Google Scholar
• Roignant JY, Soller M. m6A in mRNA: an ancient mechanism for fine-tuning gene expression. Trends Genet. 2017;33(6):380–390.
   PubMed Web of Science ®Google Scholar
• Bokar JA, Shambaugh ME, Polayes D, et al. Purification and cDNA cloning of the AdoMet-binding subunit of the human mRNA (N6-adenosine)- methyltransferase. RNA. 1997;3(11):1233–1247.
   PubMed Web of Science ®Google Scholar
• Lin S, Choe J, Du P, et al. The m(6)A methyltransferase METTL3 promotes translation in human cancer cells. Mol Cell. 2016;62(3):335–345.
   PubMed Web of Science ®Google Scholar
• Wang P, Doxtader KA, Nam Y. Structural basis for cooperative function of Mettl3 and Mettl14 methyltransferases. Mol Cell. 2016;63(2):306–317.
   PubMed Web of Science ®Google Scholar
• **Liu J, Yue Y, Han D, et al. A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat Chem Biol. 2014;10(2):93–95.
   PubMed Web of Science ®Google Scholar
• Frayling TM, Timpson NJ, Weedon MN, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007;316(5826):889–894.
   PubMed Web of Science ®Google Scholar
• Jia G, Fu Y, Zhao X, et al., N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol. 2011;7(12): 885–887.
   PubMed Web of Science ®Google Scholar
• *Zheng G, Dahl JA, Niu Y, et al. ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol Cell. 2013;49(1):18–29.
   PubMed Web of Science ®Google Scholar
• *Feng C, Liu Y, Wang G, et al. Crystal structures of the human RNA demethylase Alkbh5 reveal basis for substrate recognition. J Biol Chem. 2014;289(17):11571–11583.
   PubMed Web of Science ®Google Scholar
• Liu ZX, Li LM, Sun HL, et al. Link between m6A modification and cancers. Front Bioeng Biotechnol. 2018;6:89.
   PubMed Web of Science ®Google Scholar
• Qin Y, Li L, Luo E, et al. Role of m6A RNA methylation in cardiovascular disease. Int J Mol Med. 2020;46(6):1958–1972.
   PubMed Web of Science ®Google Scholar
• Huang H, Weng H, Sun W, et al. Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat Cell Biol. 2018 Sep;20(9):1098.
   PubMed Web of Science ®Google Scholar
• Geuens T, Bouhy D, Timmerman V. The hnRNP family: insights into their role in health and disease. Hum Genet. 2016;135(8):851–867.
   PubMed Web of Science ®Google Scholar
• Roundtree IA, Luo GZ, Zhang Z, et al. YTHDC1 mediates nuclear export of N6-methyladenosine methylated mRNAs. Elife. 2017;6:e31311.
   PubMed Web of Science ®Google Scholar
• Wang X, Zhao BS, Roundtree IA, et al., N(6)-methyladenosine modulates messenger RNA translation efficiency. Cell. 2015;161(6): 1388–1399.
   PubMed Web of Science ®Google Scholar
• *Zheng L, Tang X, Lu M, et al. microRNA-421-3p prevents inflammatory response in cerebral ischemia/reperfusion injury through targeting m6A reader YTHDF1 to inhibit p65 mRNA translation. Int Immunopharmacol. 2020;88:106937.
   PubMed Web of Science ®Google Scholar
• *Zhuang M, Li X, Zhu J, et al. The m6A reader YTHDF1 regulates axon guidance through translational control of Robo3.1 expression. Nucleic Acids Res. 2019;47(9):4765–4777.
   PubMed Web of Science ®Google Scholar
• *Weng YL, Wang X, An R, et al. Epitranscriptomic m6A regulation of axon regeneration in the adult mammalian nervous system. Neuron. 2018;97(2):313–325.e6.
   PubMed Web of Science ®Google Scholar
• Wang Y, Li Y, Toth JI, et al. N6-methyladenosine modification destabilizes developmental regulators in embryonic stem cells. Nat Cell Biol. 2014;16(2):191–198.
   PubMed Web of Science ®Google Scholar
• Wang X, Lu Z, Gomez A, et al. N6-methyladenosine-dependent regulation of messenger RNA stability. Nature. 2014;505(7481):117–120.
   PubMed Web of Science ®Google Scholar
• Xu K, Mo Y, Li D, et al. N6-methyladenosine demethylases Alkbh5/Fto regulate cerebral ischemia-reperfusion injury. Ther Adv Chronic Dis. 2020;11:2040622 320916024.
   Web of Science ®Google Scholar
• **Yi D, Wang Q, Zhao Y, et al. Alteration of N6 -methyladenosine mRNA methylation in a rat model of cerebral Ischemia-reperfusion injury. Front Neurosci. 2021;15:605654.
   PubMed Web of Science ®Google Scholar
• **Quiles-Jiménez A, Gregersen I, Mittelstedt Leal de Sousa M, et al. N6-methyladenosine in RNA of atherosclerotic plaques: an epitranscriptomic signature of human carotid atherosclerosis. Biochem Biophys Res Commun. 2020;533(4):631–637.
   PubMed Web of Science ®Google Scholar
• Wu L, Pei Y, Zhu Y, et al. Association of N6-methyladenine DNA with plaque progression in atherosclerosis via myocardial infarction-associated transcripts. Cell Death Dis. 2019;10(12):909.
   PubMedGoogle Scholar
• Jian D, Wang Y, Jian L, et al. METTL14 aggravates endothelial inflammation and atherosclerosis by increasing FOXO1 N6-methyladeosine modifications. Theranostics. 2020;10(20):8939–8956.
   PubMed Web of Science ®Google Scholar
• Si W, Li Y, Ye S, et al. Methyltransferase 3 mediated miRNA m6A methylation promotes stress granule formation in the early stage of acute ischemic stroke. Front Mol Neurosci. 2020;13:103.
   PubMed Web of Science ®Google Scholar
• Diao MY, Zhu Y, Yang J, et al. Hypothermia protects neurons against ischemia/reperfusion-induced pyroptosis via m6A-mediated activation of PTEN and the PI3K/Akt/GSK-3β signaling pathway. Brain Res Bull. 2020;159:25–31.
   PubMed Web of Science ®Google Scholar
• Yu R, Li Q, Feng Z, et al. m6A reader YTHDF2 regulates LPS-induced inflammatory response. Int J Mol Sci. 2019;20(6):1323.
   Web of Science ®Google Scholar
• *Wen L, Sun W, Xia D, et al. The m6A methyltransferase METTL3 promotes LPS-induced microglia inflammation through TRAF6/NF-κB pathway. Neuroreport. 2020;10:1097.
   Google Scholar
• Zhang Z, Wang Q, Zhao X, et al. YTHDC1 mitigates ischemic stroke by promoting Akt phosphorylation through destabilizing PTEN mRNA. Cell Death Dis. 2020;11(11):977.
   PubMed Web of Science ®Google Scholar
• Wang CX, Cui GS, Liu X, et al. METTL3-mediated m6A modification is required for cerebellar development. PLoS Biol. 2018;16(6):e2004880.
   PubMed Web of Science ®Google Scholar
• Li L, Zang L, Zhang F, et al. Fat mass and obesity-associated (FTO) protein regulates adult neurogenesis. Hum Mol Genet. 2017;26(13):2398–2411.
   PubMed Web of Science ®Google Scholar
• Wang J, Ishfaq M, Xu L, et al. METTL3/m6A/miRNA-873-5p attenuated oxidative stress and apoptosis in colistin-induced kidney injury by modulating Keap1/Nrf2 pathway. Front Pharmacol. 2019;10:517.
   PubMed Web of Science ®Google Scholar
• Shafik AM, Zhang F, Guo Z, et al. N6-methyladenosine dynamics in neurodevelopment and aging, and its potential role in Alzheimer’s disease. Genome Biol. 2021 Jan 5;22(1):17.
   PubMed Web of Science ®Google Scholar
• Oakley H, Cole SL, Logan S, et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer’s disease mutations: potential factors in amyloid plaque formation. J Neurosci. 2006;26(40):10129–10140.
   PubMed Web of Science ®Google Scholar
• Mo XB, Lei SF, Zhang YH, et al. Genome-wide enrichment of m6A-associated single-nucleotide polymorphisms in the lipid loci. Pharmacogenomics J. 2019;19(4):347–357.
   PubMed Web of Science ®Google Scholar
• Mo XB, Lei SF, Zhang YH, et al. Integrative analysis identified IRF6 and NDST1 as potential causal genes for ischemic stroke. Front Neurol. 2019;10:517.
   PubMed Web of Science ®Google Scholar
• Mo XB, Lei SF, Zhang YH, et al. Examination of the associations between m6A-associated single-nucleotide polymorphisms and blood pressure. Hypertens Res. 2019;42(10):1582–1589.
   PubMed Web of Science ®Google Scholar
• Zhu R, Tian D, Zhao Y, et al. Genome-wide detection of m6A-associated genetic polymorphisms associated with ischemic stroke. J Mol Neurosci. 2021;71(10):2107–2115.
   PubMed Web of Science ®Google Scholar
• Li J, Chen Z, Chen F, et al., Targeted mRNA demethylation using an engineered dCas13b-ALKBH5 fusion protein. Nucleic Acids Res. 2020;48(10): 5684–5694.
   PubMed Web of Science ®Google Scholar